Systemic Sclerosis: Gastrointestinal Disease and Its Management

Area of Science:

• Gastroenterology
• Rheumatology
• Internal Medicine

Background:

• The gastrointestinal tract is the most commonly affected internal organ in systemic sclerosis, impacting over 90% of patients.
• Gastrointestinal (GI) involvement significantly reduces patient quality of life and social functioning.
• Severe GI manifestations occur in 8% of patients but are associated with high mortality.

Purpose of the Study:

• To review the pathophysiology of gastrointestinal involvement in systemic sclerosis.
• To discuss current diagnostic approaches for GI manifestations.
• To outline management strategies for systemic sclerosis-related GI disease.

Main Methods:

• Literature review of recent studies on systemic sclerosis pathophysiology.
• Analysis of clinical data regarding GI involvement.
• Synthesis of information on diagnostic and therapeutic interventions.

Main Results:

• Gastrointestinal dysmotility is a key feature, with emerging insights into its underlying mechanisms.
• While treatment is largely symptomatic, understanding pathophysiology guides management.
• Comprehensive review of diagnostic tools and therapeutic options.

Conclusions:

• Gastrointestinal involvement is a major complication of systemic sclerosis requiring thorough investigation and management.
• Advances in understanding pathophysiology offer potential for improved therapeutic strategies.
• Multidisciplinary care is essential for managing patients with systemic sclerosis and GI complications.